Fidelity SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 10/31/2014 3:50:44 AM - Followers: 498 - Board type: Free - Posts Today: 7

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 

 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
CIK:  0001355250
 
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

 

Management:   http://cellceutix.com/team/
The above link is kept updated.

 
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/
 

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/
 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:
EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275
 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com
 


 
 


 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
Wiki
CTIX News: Securities Registration Statement (simplified Form) (s-3) 10/30/2014 04:31:15 PM
CTIX News: Current Report Filing (8-k) 10/24/2014 06:04:28 AM
CTIX News: ALTITRADE PARTNERS™ SAYS A KEY-REVERSAL DAY COULD HAPPEN THIS WEEK 10/14/2014 06:00:00 AM
CTIX News: Current Report Filing (8-k) 09/24/2014 03:48:22 PM
CTIX News: Annual Report (10-k) 09/15/2014 01:50:04 PM
News News Alert: Securities Registration Statement (simplified Form) (s-3) 10/30/2014 04:31:15 PM
PostSubject
#75955  Sticky Note NYSE listing requirements and Nasdaq listing requirements... BooDog 10/29/14 04:10:14 PM
#74575  Sticky Note Cellceutix Announces Positive Top-Line Data From Phase 2b TOB 10/23/14 11:59:10 AM
#73082  Sticky Note Patrick Cox interviews Cellceutix Executives Dr. Menon & sox040713 10/09/14 04:20:59 PM
#69616  Sticky Note Based on the stock movement, I think that BioHedge 09/16/14 06:47:44 PM
#67831  Sticky Note $CTIX News, SEC filings, FDA trials, misc., and KarinCA 09/03/14 06:13:02 PM
#57289  Sticky Note Cellceutix Initiates Clinical Trial of Prurisol as New starbuxsux 03/25/14 09:02:21 AM
#76199   Question: whats the difference between open shelf and steppe 10/31/14 03:50:44 AM
#76198   They couldn't sell the shares tomorrow if they KarinCA 10/31/14 01:21:03 AM
#76197   I think BioHedge's post (#76191) answers your question. sox040713 10/31/14 01:16:06 AM
#76196   CTIX just completed a phase IIb trial of KarinCA 10/31/14 01:02:36 AM
#76195   May have gotten lucky...it happens occasionally. RSI in streamingeagle88 10/31/14 01:00:16 AM
#76194   Test WanderingTrader 10/31/14 12:45:28 AM
#76193   OTC penny stock with S-3? Trader5913 10/31/14 12:42:03 AM
#76192   Tobacco co and ctix are warring ideals IMO faraifarai 10/30/14 11:37:49 PM
#76191   The shelf registration is all about flexibility. It BioHedge 10/30/14 11:35:43 PM
#76190   Questions for BigKahuna and Noretreat, why Leo couldn't monkeyplay1 10/30/14 11:32:54 PM
#76189   Yes, we went through this with the tobacco Pepsiman2001 10/30/14 11:30:02 PM
#76187   FAQ pdf on shelf offerings, very interesting read. jok 10/30/14 11:26:56 PM
#76186   I was thinking/guessing the same, a platform, not EasyRider 10/30/14 11:20:47 PM
#76185   Yes, think B-OM. Oral mucositis. Inflammation. biodoc 10/30/14 11:17:05 PM
#76184   I'm good, not planning to do anything. I lousy engineer 10/30/14 11:16:26 PM
#76183   If you're so convinced, sell now and buy etradeedge 10/30/14 11:13:14 PM
#76182   In your opinion! In my opinion it goes daydreaming2 10/30/14 11:04:25 PM
#76181   That should calm any nervous holder. Tails 10/30/14 11:04:18 PM
#76180   Lousy Engineer, the 75 million is just a Whoops 10/30/14 10:58:31 PM
#76179   This S-3 means more shares dilution. If he lousy engineer 10/30/14 10:52:26 PM
#76178   So this secondary is essentially timed to the Whoops 10/30/14 10:51:41 PM
#76177   And I hope Leo continues to run Cellceutix etradeedge 10/30/14 10:45:19 PM
#76176   80+ percent of companies on the big exchanges Pepsiman2001 10/30/14 10:42:59 PM
#76175   Yes, talked about the backbone of B and TheMonolith 10/30/14 10:42:57 PM
#76174   Leo = Bumgarner TheMonolith 10/30/14 10:26:56 PM
#76173   $75 millions is a huge amount of money. lousy engineer 10/30/14 10:20:34 PM
#76172   I have arthritis and I'm sure millions of Ultimate01 10/30/14 10:18:19 PM
#76171   I am somewhat lost, but from everything that tnbc2012 10/30/14 10:15:57 PM
#76170   I get excited easily but Im going to Ultimate01 10/30/14 10:15:43 PM
#76169   I listened to the Patrick Cox interview with Darwinian 10/30/14 10:09:45 PM
#76168   I just read the portion of the S-3 TheDane 10/30/14 10:07:33 PM
#76167   I will be waiting with my finger on tombrady12nh 10/30/14 09:44:48 PM
#76166   Thats what caught my eye. Its been Ultimate01 10/30/14 09:32:44 PM
#76165   I have read the thoughts from the worry jok 10/30/14 09:31:56 PM
#76164   Not sure. Found this on Wikipedia: EasyRider 10/30/14 09:28:41 PM
#76163   I believe that would be P, no? Apparition 10/30/14 09:24:45 PM
#76162   Reading through the S-3... it reeks of success...! EasyRider 10/30/14 09:23:00 PM
#76161   I read your post several times and I F1ash 10/30/14 09:21:24 PM
#76160   Can antibiotics be considered anti-inflammatory? EasyRider 10/30/14 09:20:59 PM
#76159   Very intriguing change in description. It can't be TheDane 10/30/14 09:19:21 PM
#76158   A few interesting tidbits: EasyRider 10/30/14 09:16:18 PM
#76157   That's so funny! I thought of him when Apparition 10/30/14 09:16:07 PM
#76156   Ha! I do wish Biomanbaba was here to MrW 10/30/14 09:13:14 PM
#76155   What an f'in curve ball though, huh? Apparition 10/30/14 09:07:06 PM
#76154   I figure/fantasize that a big pharma would want Ultimate01 10/30/14 09:05:18 PM
#76153   The wind shakes the barley. If not tomorrow, then faraifarai 10/30/14 08:53:31 PM
#76152   I'm not sure that I understand what part loanranger 10/30/14 08:48:11 PM
#76151   I think this all smells of a deal. Ultimate01 10/30/14 08:43:42 PM
#76150   "Some shelf registrations are done to cover deals loanranger 10/30/14 08:42:06 PM
#76146   Love the play by Leo. Shows so much Swish22 10/30/14 08:21:47 PM
PostSubject